Key points are not available for this paper at this time.
Reslizumab is an effective therapy for SEUA with adequate safety profile in real-life conditions.
Llano et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: